LIFE INSURANCE COMPANIES TAKE LEAP OF FAITH

Similar documents
Do you. chronic conditions. for customers

DO YOU UNDERSTAND CHRONIC CONDITIONS AND HIV? FOR CUSTOMERS

Understanding Epidemics Section 2: HIV/AIDS

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association

Public-Private Partnerships: Limelight on Diabetes. Renuka Gadde VP, Global Health October 18, 2012

ART for prevention the task ahead

Index. Research Objective. Health Issues in SA Non-communicable diseases Diabetes Cancer Hypertension. Communicable Diseases HIV AIDS TB

COMMUNITY HEALTH NEEDS ASSESSMENT IMPLEMENTATION STRATEGY

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association

Why Non communicable Diseases? Why now?

International Partnership for Microbicides

Lecture Outline: HIV/AIDS in. Africa

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

Okinawa, Toyako, and Beyond: Progress on Health and Development

Children and AIDS Fourth Stocktaking Report 2009

Partners for Health Reformplus. Strengthening Health System Responses to HIV/AIDS

Mark Skidmore Michigan State University North Central Regional Center for Rural Development

Peace Corps Global HIV/AIDS Strategy (FY )

Save the Children President s Emergency Plan OVC Programming. Stacy Rhodes Director, HIV/AIDS Office April 19th, 2005

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

Role of UN Agencies in Achieving the Sustainable Development Goals (SDG 3.4)

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

Diabetes. Ref HSCW 024

A public health perspective on the importance of good nutrition within and beyond school. Linda de Caestecker Director of Public Health

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Media centre Obesity and overweight

Global Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010

REPORT FROM THE COMMISSION. Annual Report ( )

DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI

UN Panel Discussion Millennium Development Goals. Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010

ChildrenBlocksLayout_presentation.indd 1. World AIDS Day 2008

ENDING AIDS, TB AND MALARIA AS EPIDEMICS

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

UNIVERSITY OF CHICAGO MEDICINE & INSTITUTE FOR TRANSLATIONAL MEDICINE COMMUNITY BENEFIT FY 2016 ADULT DIABETES GRANT GUIDELINES

Microfinance and HIV/AIDS. DONOR INFORMATION RESOURCE CENTRE Helping to Improve Donor Effectiveness in Microfinance

ADDRESSING CHRONIC DISEASES

Notes for Remarks Dr. Jan Hux, President and Kimberley Hanson, Director, Federal Affairs Diabetes Canada. To the Standing Committee on Health

National HIV/STI Programme Overview

lovelife is a new lifestyle brand for young South Africans promoting healthy living and positive sexuality. Organised under the auspices of Mrs.

Approximately one third of the 15.7 million Americans who are estimated to have diabetes

Marginalized Groups as Agents of Change in HIV and AIDS: YOPAD - a story from Dar es salaam Tanzania

Diabetes. Halt the diabetes epidemic

Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria

Contextual overview with reference to MDG Goal 6 and projection for Post-2015

The Struggle with Infectious Disease. Lecture 6

Renewing Momentum in the fight against HIV/AIDS

The Millennium Development Goals. A Snapshot. Prepared by DESA based on its annual Millennium Development Goals Report

HEALTH I AM 1. of MANY AND WELFARE INITIATIVES. SOUTH AFRICANS THAT HAVE BENEFITTED FROM ANGLO AMERICAN S

The TRUE Guide to Diabetes Care

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND

Cardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health

Key Messages for World Malaria Day 2009

The Journey towards Total Wellbeing A Health System s Innovative Approach

HIV/AIDS in East Asia

Senior Leaders and the Strategic Alignment of Community Benefit Programs: The Example of Diabetes

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Diabetes - The Facts

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Scaling up priority HIV/AIDS interventions in the health sector

NAMIBIA INVESTMENT CASE

Innovation, Access and Use Department of Essential Medicines and Health Products WHO

SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES

Volume 1, Issue 1. Healthy Ageing. A g e i n g w i t h a S m i l e I n i t i a t i v e

SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES

The Investment Framework

Combatting noncommunicable diseases global burden and best practices

Tackling Type 2 Diabetes in the US: Translating Science into Public Policies and Actions

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

unexpected costs New Severe Illness offering Sanlam Group Risk Cover Severe Illness insurance Sales Aid

HEAIDS CONFERENCE 2017

PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name

COSTS OF DIABETES IN DEVELOPING COUNTRIES

Assessing the Impact of HIV/AIDS: Information for Policy Dialogue

Health Care Reform Update and Advocacy Priorities

Good Health & Well-Being. By Alexandra Russo

HIV AND AIDS FACT SHEETS

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

combat HIV/AIDS, malaria and other diseases

5. Cardiovascular Disease & Stroke

What role can we play? As: the College ACSEP? clinicians? community leaders individuals

Combating. Across Africa. and. Brain Wrinkles

Latest Funding Trends in AIDS Response

Baptist Health Beaches Community Health Needs Assessment Priorities Implementation Plans

Heart disease and stroke major health problems

UNAIDS 2013 AIDS by the numbers

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.

The Global Alliance for Improved Nutrition

Nutrition and Physical Activity Situational Analysis

SADAG submission to the Competition Commission: Market Inquiry into the Private Healthcare Sector

#IGObesity16. Richard Sangster Team Leader Obesity Policy Department of Health

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Why should AIDS be part of the Africa Development Agenda?

Government of Canada Federal AIDS Initiative Milestones

2. SITUATION ANALYSIS

Creating Policy to Promote and Support Individual Change. Ann Albright, PhD, RD

After simple testing that only takes minutes people with elevated test results are then recommended to see their physicians for follow-up.

Transcription:

LIFE INSURANCE COMPANIES TAKE LEAP OF FAITH

Cover for HIV positive and diabetic lives QED Actuaries & Consultants Craig Falconer 1 December 2017

OVERVIEW HIV Product Diabetes Product Key success Factors Application in Caribbean?

LIFE INSURANCE FOR HIV + PEOPLE LAUNCHED IN SOUTH AFRICA, 2005 Johannesburg - South African insurance product designer and administrator, AllLife, Wednesday launched the first ever affordable broad based life insurance offering for people living with HIV in this country. In a first time for South Africa, people living with HIV can now easily access life insurance cover for up to 1 million rand (about 70,000 US dollars). AllLife Managing Director Ross Beerman said in a country which constitutionalizes equality, HIV+ individuals have been routinely discriminated against by the insurance industry. Insurance policy applications by people living with HIV or those found to be HIV+ on application are consistently declined.

HIV PRODUCT What is HIV/AIDS? AIDS/HIV in South Africa AIDS/HIV in the Caribbean Description of the Product The Adherence Program

What is HIV/AIDS? HIV is a an auto-immune disease that attacks the immune system Reduces body s ability to protect itself from diseases People with HIV normally die from opportunistic infections such as TB, pneumonia, forms of cancer The CD4 count is used to test how advanced the HIV infection is Normal CD4 count is over 900 Once the CD4 count drops below 200 a person is considered to have full blown AIDS This therefore also coincides with evidence of various opportunistic infections

AIDS/HIV in South Africa South Africa has worst HIV epidemic in the world 18.9% prevalence among adults 7 million people are HIV positive (SA population is just under 50 million) 110,000 AIDS deaths in 2016 2.3 million AIDS orphans 55% of the population are on ARV s Largest ARV program globally 1.5 billion USD a year

AIDS/HIV in the Caribbean Second highest prevalence in the world after sub-saharan Africa 1% prevalence or around 250,000 people Has been declining Key reasons are mainly social vulnerability due to poverty, unemployment, sex tourism and stigma Females higher than male prevalence (only region outside Africa). Prevalence higher in men to men Mainly spread through heterosexual means Haiti highest at around 2%. Cuba lowest due to government interventions

Description of the Product Simple Whole Life Term, 5 and 10 year term and mortgage cover Disability Rider Direct Sales (website, internet, advertising) Fully reinsured GenRe No waiting period CD4 count above 200 to be eligible Affordable cover 2.5% to 8.5% annual premium (depending on age, smoking status, type of cover, etc) Claim not paid if Adherence program not followed

The Adherence Program Designed to extend the life and quality of life of the policyholder Policyholder must commit to it and stick to it Blood tests every 6 months (to monitor) May need to provide proof of purchase of ARV s Must commit to take the ARV s every 24, 12 or 8 hours depending on dosage (at exact same time each day) If CD4 or viral load deteriorates implies non-adherence of becoming resistant Triggers action i.e. change ARV program with their doctor If All Life is confident they are adherent and patient not responding to alternative ARV regime, will pay Will not pay if non-adherent (except accident claims) Policyholder can appeal. The appeal will be independently reviewed by the South African HIV Clinicians Society.

DIABETES PRODUCT What is Diabetes? Diabetes in South Africa Diabetes in the Caribbean Description of the Product The Adherence Program

What is Diabetes? Type 1 - the body does not produce any insulin Type 2 body produces too little or insulin doesn t work Insulin is needed to help the body process glucose for energy Too little insulin implies low energy levels and high glucose in the blood High glucose results in bacterial infections The body may burn fat for energy resulting in weight loss The kidney responds to try and flush out the glucose resulting in kidney complications Leads to heart disease, stroke, kidney failure, blindness, amputations Treatment includes exercise and diet to normalize glucose levels and insulin injections

Diabetes in South Africa 7% of SA adult population has diabetes Additional 4 million in early stages Incidence in Africa generally is around 7% but expected to double by 2030 Reasons are urbanization and obesity Diet changes to high fat, sugar and salt Lower exercise more sedentary lifestyle

Diabetes in the Caribbean Prevalence is 9.6% of adult population Haiti lowest at 7% Others at 14% Accounts for 14% of deaths Major public health challenge High incidence due to diet, sedentary lifestyle and obesity

Description of the Product Whole Life and Loan Protection Disability Rider Rates depend on type of diabetes And duration since diagnosed And normal rating factors (age, smoking status, gender) Only offered if HbA1c level is below 14%, cholesterol below 8.5 Standard exclusions such as pre-existing and suicide

Diabetes Control Program HbA1c blood test every 12 months If the level improves then premium reduces If the level deteriorates premium increases If test not received then premium increases Claim paid if demonstrate adherence

KEY SUCCESS FACTORS Market/need Technology Partners Product design

Technology Medical advances Technology supports the disease management and risk controls Facilitates quick acceptance and on-boarding Facilitates innovative risk assessment and ongoing underwriting Dynamic premium rating

Partners GenRe Smaller agile insurer Clinician Society and relevant medical bodies Blood clinics Funding partners

Product design Adherence program to manage risks Simple product Technology to make the processes efficient Risk managed using technology Direct sales distribution

APPLICATION IN CARIBBEAN? HIV also high but the prevalence no where near SA market so perhaps limited demand/need All Life success is also more in the middle to upper income (not lower mass market) Diabetes has more demand and need so is probably potential to offer this in some countries here Can visit All Life website and develop from scratch however technology will take time to implement Could consider partnership with All Life Regional collaboration to provide scale?

Thank You Any Questions? Craig Falconer QED Actuaries & Consultants (Pty) Ltd Tel: +27 11 038-3705 Email: Craig.Falconer@qedactuarial.co.zac Heinrich Wessels QED Actuaries & Consultants (Pty) Ltd Tel: +27 11 038-3709 Email: Heinrich.Wessels@qedactuarial.co.za